Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis.

Published in: The Journal of dermatological treatment (2024)

Lower total EASI and higher age may predict responders to upadacitinib 15 mg while lower IgE and lower LDH may predict responders to 30 mg.

Keyphrases